medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 05

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (05)

Findings in colposcopy. Experience in a reference unit

Ciendua G, Ortiz N, Alvarado C, Valderrama A, Colmenares CC

Language: Spanish
References: 21
Page: 302-310
PDF size: 301.27 Kb.


ABSTRACT

Objective: This study describes the colposcopic results of patients with cytological alterations in a Colombian institution.
Materials and Methods: Observational Cross-sectional study based on retrospective data. Patients who underwent colposcopy due to abnormal cytologies during 2012-2106 were included. A stratified random sampling was carried out by age groups. The frequencies of colposcopic alterations and histological results were established.
Results: 372 patients were selected. The main indication for colposcopy was the ASCUS report (70.6%), followed by LSIL (16.9%) and endocervical polyps (2.9%). Colposcopy was negative in 32% of the cases, positive in 31% and inflammation in 21%. The rest of cases corresponded to varied findings such as atrophy or polyps. Of the positive colposcopies the main report was minor changes or grade 1; especially in patients between 15-24 years. Of the patients with a biopsy, one case of adenocarcinoma (3.1%) and another of carcinoma in situ (3.1%) were reported in the same age group.
Conclusions:: The realization of colposcopy identified the high-grade lesions in this population, but also detected clinically insignificant low-grade lesions. Colposcopy is a key tool for the diagnosis of premalignant lesions of the cervix.


REFERENCES

  1. Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12.

  2. Bornstein J, et al. 2011 Colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2012; 120:166-72. doi: 10.1097/AOG.0b013e318254f90c.

  3. Ferlay J, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 2014;136(5):359- 86. https://doi.org/10.1002/ijc.29210.

  4. Boletín de información técnica especializada. Cáncer de cuello Uterino. Fondo Colombiano de enfermedades de alto costo. [cited 21 March 2018] .Available from: https:// cuentadealtocosto.org/site/images/Publicaciones/2018/ Dia_Mundial_de_la_Prevencion_del_Cancer_de_Cuello_ Uterino.

  5. Wright TC, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 2012; 206(1), 46.e1-46.e11. https://doi.org/10.1016/j. ajog.2011.07.024

  6. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188:1393-400. https://doi.org/10.1067/mob.2003.462

  7. Khan MJ, et al. ASCCP Colposcopy Standards: Role of Colposcopy, benefits, potential harms, and terminology for colposcopy practice. Journal of Lower Genital Tract Disease 2017;21(4):223-29. doi: 10.1097/LGT.0000000000000338

  8. Solomon D, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114. doi:10.1001/jama.287.16.2114

  9. Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol 2015; 123:271. https://doi.org/10.1016/j. jasc.2015.01.002.

  10. Nayar R, Wilbur DC. The Pap Test and Bethesda 2014: “The reports of my demise have been greatly exaggerated.” (after a quotation from Mark Twain). Acta Cytologica 2015; 59(2):121-32. https://doi. org/10.1159/000381842

  11. Castle PE, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol 2009;114:365-69. https://doi.org/10.1016/j.ygyno.2009.04.035

  12. Rositch AF, et al. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res 2012; 72:6183. doi: 10.1158/0008-5472.

  13. Maglennon GA, Doorbar J. The biology of papillomavirus latency. Open Virol J 2012; 6:190-97. doi: 10.2174/18743 57901206010190

  14. Bifulco G, et al. A prospective randomized study on limits of colposcopy and histology: the skill of colposcopist and colposcopy-guided biopsy in diagnosis of cervical intraepithelial lesions. Infectious Agents and Cancer 2015;10:47. https://doi.org/10.1186/s13027-015-0042-9

  15. Bouchard-Fortier G, et al. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis. J Obstet Gynaecol Can. 2013 Feb;35(2):149-55. https://doi. org/10.1016/S1701-2163(15)31020-3

  16. Nakamura Y, et al. Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study. International Journal of Clinical Oncology 2014;20(3):579-85. https://doi.org/10.1007/s10147-014-0739-6

  17. López-Alegría F, et al. Clinical management of the first ASCUS report in Chile. first ASCUS report in Chile. Prospective single-cohort study. Sao Paulo Medical Journal 2015;133(6):480-87. http://dx.doi.org/10.1590/1516- 3180.2014.9142511

  18. Kabaca C, et al. The importance of immediate verification of a cervical cytological abnormality with histology. Indian Journal of Cancer 2013:50(4):292. doi: 10.4103/0019- 509X.123591

  19. Asotic A, et al. Correlation of Cervical Smear and Pathohistological Findings. Med Arh. 2014 Apr; 68(2):106- 109. doi: 10.5455/medarh.2014.68.106-109

  20. Waxman AG, et al. ASCCP Colposcopy Standards: How do we perform colposcopy? Implications for establishing standards. J Low Genit Tract Dis. 2017;21(4):235-41. doi: 10.1097/LGT.0000000000000336

  21. Jayasinghe YL, et al. Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service. J Low Genit Tract Dis. 2016 Jul;20(3):224-9. doi: 10.1097/LGT.0000000000000217




2020     |     www.medigraphic.com